ENCAPTASE Trademark

Trademark Overview

On Wednesday, December 5, 2007, a trademark application was filed for ENCAPTASE with the United States Patent and Trademark Office. The USPTO has given the ENCAPTASE trademark a serial number of 77344564. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 15, 2011. This trademark is owned by Curemark, LLC. The ENCAPTASE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pervasive developmental disorders, dysautonomia, and neurological disorders
encaptase

General Information

Serial Number77344564
Word MarkENCAPTASE
Filing DateWednesday, December 5, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 15, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 22, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of pervasive developmental disorders, dysautonomia, and neurological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 10, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCuremark, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRye, NY 10580
Party NameCuremark, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressYonkers, NY 10704

Trademark Events

Event DateEvent Description
Monday, August 15, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 15, 2011ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 6, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 6, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 21, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 20, 2011EXTENSION 5 GRANTED
Saturday, January 15, 2011EXTENSION 5 FILED
Tuesday, January 18, 2011TEAS EXTENSION RECEIVED
Wednesday, October 20, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 19, 2010EXTENSION 4 GRANTED
Thursday, July 15, 2010EXTENSION 4 FILED
Monday, October 18, 2010EXTENSION RECEIVED WITH TEAS PETITION
Monday, October 18, 2010PETITION TO REVIVE-GRANTED
Monday, October 18, 2010TEAS PETITION TO REVIVE RECEIVED
Monday, August 16, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 16, 2010ABANDONMENT - NO USE STATEMENT FILED
Friday, February 19, 2010EXTENSION 3 GRANTED
Friday, January 15, 2010EXTENSION 3 FILED
Friday, February 19, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 15, 2010TEAS EXTENSION RECEIVED
Thursday, July 16, 2009EXTENSION 2 GRANTED
Wednesday, July 15, 2009EXTENSION 2 FILED
Wednesday, July 15, 2009TEAS EXTENSION RECEIVED
Monday, February 2, 2009EXTENSION 1 GRANTED
Thursday, January 15, 2009EXTENSION 1 FILED
Monday, February 2, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 15, 2009TEAS EXTENSION RECEIVED
Tuesday, July 15, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 22, 2008PUBLISHED FOR OPPOSITION
Wednesday, April 2, 2008NOTICE OF PUBLICATION
Wednesday, March 19, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 19, 2008ASSIGNED TO LIE
Saturday, March 15, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 15, 2008ASSIGNED TO EXAMINER
Monday, December 10, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

encaptase disorders dysautonomia neurological developmental pervasive preparations treatment pharmaceutical